
  
    
      
        
        Approximately_RB 40_CD %_NN of_IN the_DT world_NN 's_POS population_NN ,_, mostly_RB living_VBG in_IN the_DT world_NN 's_POS poorest_JJS
        countries_NNS ,_, is_VBZ at_IN risk_NN of_IN malaria_NN ._. In_IN the_DT tropical_JJ and_CC subtropical_JJ regions_NNS of_IN the_DT world_NN ,_,
        malaria_NN causes_NNS 300_CD million_CD acute_JJ illnesses_NNS and_CC at_IN least_JJS 1_CD million_CD deaths_NNS annually_RB ._. Ninety_CD
        percent_NN of_IN these_DT deaths_NNS occur_VBP in_IN Africa_NNP ,_, south_RB of_IN the_DT Sahara_NNP ,_, mostly_RB among_IN young_JJ
        children_NNS ._.
        To_TO assess_VB disease_NN severity_NN ,_, peripheral_JJ blood_NN parasitemia_NN is_VBZ measured_VBN ,_, but_CC this_DT is_VBZ only_RB a_DT
        weak_JJ predictor_NN of_IN mortality_NN in_IN falciparum_NN malaria_NN ._. In_IN addition_NN ,_, a_DT microscopist_NN is_VBZ only_RB able_JJ
        to_TO count_VB the_DT less_RBR pathogenic_JJ circulating_VBG stages_NNS of_IN the_DT parasite_NN ,_, whereas_IN the_DT more_RBR
        pathogenic_JJ parasitized_JJ erythrocytes_NNS ,_, sequestered_VBN in_IN the_DT capillaries_NNS and_CC containing_VBG mature_VBP
        parasites_NNS ,_, are_VBP not_RB seen_VBN and_CC therefore_RB not_RB counted_VBN ._. However_RB ,_, sequestered_VBN 
        Plasmodium_NNP falciparum_NN parasites_NNS secrete_NN Histidine-rich_NNP protein_NN 2_CD
        (_( PfHRP_NNP 2_LS )_) ,_, which_WDT is_VBZ liberated_VBD into_IN the_DT plasma_NN at_IN schizont_NN rupture_NN ._.
        In_IN this_DT month_NN 's_POS 
        PLoS_NNP Medicine_NNP ,_, Arjen_NNP Dondorp_NNP and_CC colleagues_NNS suggest_VBP that_IN the_DT plasma_NN
        concentration_NN of_IN this_DT protein_NN might_MD provide_VB a_DT better_JJR estimate_NN for_IN the_DT patient_NN 's_POS total_JJ
        parasite_NN biomass_NNS and_CC therefore_RB be_VB a_DT more_RBR accurate_JJ prognostic_JJ indicator_NN than_IN circulating_VBG
        parasite_NN load_NN ._. There_EX is_VBZ evidence_NN to_TO support_VB this_DT hypothesis_NNS ._. A_DT recent_JJ study_NN by_IN the_DT same_JJ
        team_NN measured_VBD PfHRP_NNP 2_CD in_IN 
        P_NN ._. falciparum_NN cultures_NNS ,_, and_CC showed_VBD that_IN approximately_RB 89_CD %_NN of_IN
        PfHRP_NNP 2_CD is_VBZ liberated_VBD at_IN schizont_NN rupture_NN and_CC that_IN the_DT variation_NN in_IN the_DT amount_NN released_VBN is_VBZ
        limited_VBN ._.
        In_IN the_DT current_JJ study_NN the_DT researchers_NNS measured_VBD plasma_NN PfHRP_NNP 2_CD concentrations_NNS in_IN 337_CD
        patients_NNS with_IN varying_VBG severity_NN of_IN falciparum_NN malaria_NN and_CC ,_, using_VBG a_DT simple_JJ mathematical_JJ
        model_NN ,_, estimated_VBD the_DT total_JJ body_NN parasite_NN biomass_NNS ._. This_DT value_NN was_VBD compared_VBN with_IN measures_NNS of_IN
        disease_NN severity_NN and_CC outcome_NN ._. The_DT developmental_NN stage_NN distribution_NN of_IN circulating_VBG
        parasites_NNS ,_, which_WDT also_RB provides_VBZ information_NN on_IN the_DT sequestered_VBN parasites_NNS ,_, was_VBD also_RB evaluated_VBN
        in_IN relation_NN to_TO plasma_NN PfHRP_NNP 2_CD levels_NNS in_IN these_DT patients_NNS ._.
        The_DT researchers_NNS found_VBD that_IN the_DT estimated_VBN geometric_JJ mean_NN parasite_NN burden_NN was_VBD more_JJR than_IN
        six_CD times_NNS higher_JJR in_IN patients_NNS with_IN severe_JJ malaria_NN than_IN in_IN patients_NNS hospitalized_VBN without_IN
        signs_NNS of_IN severe_JJ disease_NN ,_, and_CC was_VBD highest_JJS in_IN patients_NNS who_WP died_VBD ._. Statistical_NNP analysis_NN
        revealed_VBD that_IN the_DT estimated_VBN total_JJ parasite_NN biomass_NNS was_VBD clearly_RB associated_VBN with_IN disease_NN
        severity_NN and_CC outcome_NN ._. By_IN contrast_NN ,_, peripheral_JJ blood_NN parasitemia_NN and_CC the_DT number_NN of_IN
        circulating_VBG parasites_NNS were_VBD not_RB associated_VBN with_IN disease_NN outcome_NN ,_, nor_CC with_IN other_JJ measures_NNS of_IN
        severity_NN such_JJ as_IN admission_NN plasma_NN lactate_NN concentrations_NNS ._.
        The_DT finding_VBG that_WDT sequestered_VBN parasite_NN biomass_NNS is_VBZ associated_VBN with_IN disease_NN severity_NN fits_VBZ
        with_IN current_JJ thinking_NN that_DT sequestration_NN of_IN erythrocytes_NNS containing_VBG the_DT mature_VBP forms_NNS of_IN the_DT
        parasite_NN is_VBZ the_DT central_JJ pathological_JJ process_NN in_IN falciparum_NN malaria_NN ._.
        However_RB ,_, the_DT team_NN noted_VBD there_EX were_VBD several_JJ factors_NNS that_WDT might_MD contribute_VB to_TO inaccuracies_NNS
        in_IN the_DT model_NN ._. For_IN example_NN ,_, the_DT amount_NN of_IN PfHRP_NNP 2_CD secreted_JJ per_IN parasite_NN varies_VBZ between_IN
        different_JJ parasite_NN strains_NNS ._. Also_RB ,_, in_IN high_JJ transmission_NN areas_NNS ,_, where_WRB partial_JJ immunity_NN
        against_IN the_DT disease_NN develops_VBZ ,_, clearance_NN of_IN PfHRP_NNP 2_CD might_MD be_VB increased_VBN in_IN the_DT presence_NN of_IN
        antibodies_NNS against_IN the_DT protein_NN ;_: in_IN these_DT areas—such_NN as_IN countries_NNS in_IN sub-_NN Saharan_NNP Africa—the_NNP
        model_NN would_MD thus_RB underestimate_NN the_DT parasite_NN burden_NN and_CC might_MD need_VB to_TO be_VB adapted_VBN further_RB for_IN
        use_NN ._.
        Despite_IN these_DT issues_NNS ,_, estimates_NNS of_IN plasma_NN PfHRP_NNP 2_CD concentrations_NNS may_MD be_VB useful_JJ as_IN a_DT
        research_NN tool_NN to_TO stratify_NN patients_NNS '_POS parasite_NN loads_NNS ,_, say_VBP the_DT authors_NNS ._. They_PRP conclude_VBP that_IN
        quantitative_JJ measurements_NNS of_IN plasma_NN PfHRP_NNP 2_CD in_IN patients_NNS with_IN falciparum_NN malaria_NN could_MD be_VB
        used_VBN to_TO estimate_VB the_DT total_JJ parasite_NN biomass_NNS ,_, a_DT parameter_NN pivotal_JJ in_IN the_DT pathophysiology_NN of_IN
        the_DT disease_NN ,_, and_CC that_IN this_DT total_JJ parasite_NN biomass_NNS is_VBZ associated_VBN with_IN clinical_JJ measures_NNS of_IN
        the_DT severity_NN of_IN the_DT disease_NN ._.
      
    
  
